Want to join the conversation?
$MCO 2Q15 Call: MA global revenue was $279MM, up 12% YoverY. MA’s US revenue was up 23% and non-US revenue was up 4%. Global revenue from RD&A was $158MM, up 11% YoverY. Growth was mainly due to the Oct. 2014 acquisition of Lewtan Technologies as well as strong performance in the credit research and content licensing businesses.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?